Memantine: a treatment for Alzheimer’’s disease with a new formulation

Author： Makino Kelly M   Porsteinsson Anton P  

Publisher： Future Medicine

ISSN： 1745-509X

Source： Aging Health, Vol.7, Iss.3, 2011-06, pp. : 349-362

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Memantine in the treatment of Alzheimer’s disease

By Porsteinsson Anton P   Cosman Kelly M  

Aging Health, Vol. 2, Iss. 6, 2006-12 ,pp. : 891-904

Future Medicine

Access to resources Recommend Favorite

Cholinesterase inhibitors and memantine in more advanced Alzheimer’s disease: the debate continues

By Dwolatzky Tzvi   Clarfield A Mark  

Aging Health, Vol. 8, Iss. 3, 2012-06 ,pp. : 233-237

Future Medicine

Access to resources Recommend Favorite

Treatment of latent stage Alzheimer’’s disease with statins?

By Li Gail   Sonnen Joshua A   Montine Kathleen S   Montine Thomas J  

Aging Health, Vol. 5, Iss. 1, 2009-02 ,pp. : 29-32

Future Medicine

Access to resources Recommend Favorite

Donepezil in the treatment of severe Alzheimer’s disease

By Richard Jennifer L   Cosman Kelly M   Porsteinsson Anton P  

Aging Health, Vol. 3, Iss. 4, 2007-08 ,pp. : 419-435

Future Medicine

Access to resources Recommend Favorite

New treatments for Alzheimer’s disease: how close are we?

By Kuret Jeff  

Aging Health, Vol. 3, Iss. 4, 2007-08 ,pp. : 445-448

Future Medicine

Access to resources Recommend Favorite